Heart murmurs

Eko’s AI Analysis Algorithm Validated as a Clinical Tool for Detecting Heart Murmurs

Retrieved on: 
Monday, May 10, 2021

The findings suggest utility of the FDA-cleared Eko AI algorithm as a frontline clinical tool to aid clinicians in screening for cardiac murmurs that may be caused by valvular heart disease.\nAlgorithm performance for detecting murmurs was found to have sensitivity of 90.0% and specificity of 91.4%, when excluding grade 1 murmurs which are difficult to hear.

Key Points: 
  • The findings suggest utility of the FDA-cleared Eko AI algorithm as a frontline clinical tool to aid clinicians in screening for cardiac murmurs that may be caused by valvular heart disease.\nAlgorithm performance for detecting murmurs was found to have sensitivity of 90.0% and specificity of 91.4%, when excluding grade 1 murmurs which are difficult to hear.
  • The NIH-sponsored, multisite study published in the Journal of the American Heart Association was the largest study on AI analysis of cardiac murmurs.
  • \xe2\x80\x9cIt takes expert clinicians many years to master the art of hearing and interpreting heart murmurs, and there is still a lot of variability.
  • \xe2\x80\x9cNow for the first time, artificial intelligence is being applied to stethoscopic heart sounds to improve the auscultation skills of health care professionals.

Global Stethoscopes Market Insights, 2020-2025 - Growing Concerns Over Stethoscopes as Intra-Hospital Carriers of Pathogenic Infections Augments the Rise of Disposable Stethoscopes

Retrieved on: 
Tuesday, January 28, 2020

DUBLIN, Jan. 28, 2020 /PRNewswire/ -- The "Stethoscopes - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 28, 2020 /PRNewswire/ -- The "Stethoscopes - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • A key benefit of these stethoscopes is their ability to detect and record cardiac murmurs as low as 8 Khz.
  • Manual and mechanical stethoscopes will however continue to dominate the market, driven by their huge popularity among medical practitioners worldwide.
  • A key trend in the market is the rise of disposable stethoscopes against a backdrop of growing concerns over stethoscope as intra-hospital carriers of pathogenic infections.

FDA Clears Eko’s AFib and Heart Murmur Detection Algorithms, Making It the First AI-Powered Stethoscope to Screen for Serious Heart Conditions

Retrieved on: 
Tuesday, January 28, 2020

Ekos new ability to alert a provider to the presence of a heart murmur or atrial fibrillation during the standard physical exam brings that vision to life.

Key Points: 
  • Ekos new ability to alert a provider to the presence of a heart murmur or atrial fibrillation during the standard physical exam brings that vision to life.
  • Patients with valvular heart disease and AFib often go undiagnosed during the physical exam.
  • Murmurs indicative of valvular or structural heart disease can be extremely difficult for clinicians to hear and AFib may not be detected during the physical exam.
  • Ekos AI is able to identify heart murmurs, a leading symptom of valvular heart disease, with 87% sensitivity and 87% specificity.

eMurmur receives CE mark certification for its heart murmur detection solution

Retrieved on: 
Wednesday, June 12, 2019

OTTAWA, June 12, 2019 /PRNewswire/ - eMurmur announced today that its flagship "eMurmur ID" solution has received the CE mark certification.

Key Points: 
  • OTTAWA, June 12, 2019 /PRNewswire/ - eMurmur announced today that its flagship "eMurmur ID" solution has received the CE mark certification.
  • eMurmur ID is a mobile and cloud solution which operates in conjunction with a 3rdparty electronic stethoscope.
  • It uses advanced machine learning to identify and classify pathologic and innocent heart murmurs, the absence of a heart murmur, and S1, S2 heart sounds.
  • eMurmur launched an early access program available at https://emurmur.com/clinical , designed to give early adopters full access to eMurmur ID.

FDA grants clearance for a heart murmur detection solution on a personal mobile device

Retrieved on: 
Tuesday, May 14, 2019

OTTAWA, May 14, 2019 /PRNewswire/ -eMurmur today announced that its flagship "eMurmur ID" solution has received FDA clearance, enabling a new era in heart murmur detection.

Key Points: 
  • OTTAWA, May 14, 2019 /PRNewswire/ -eMurmur today announced that its flagship "eMurmur ID" solution has received FDA clearance, enabling a new era in heart murmur detection.
  • eMurmur ID is a mobile and cloud solution which operates in conjunction with a 3rdparty electronic stethoscope.
  • It uses advanced machine learning to identify and classify pathologic and innocent heart murmurs, the absence of a heart murmur, and S1, S2 heart sounds.
  • The end-to-end solution is comprised of AI-based analytics, a mobile app, and a web portal (all HIPAA compliant).

Transcatheter Mitral Valve Repair Device Market, Europe, Units Sold, Average Selling Prices, Forecasts, 2018-2024, MedCore

Retrieved on: 
Wednesday, October 10, 2018

Growth will be driven by the large potential patient population, improved diagnostic capabilities, new product launches, positive clinical results and favorable reimbursement conditions.

Key Points: 
  • Growth will be driven by the large potential patient population, improved diagnostic capabilities, new product launches, positive clinical results and favorable reimbursement conditions.
  • It is worth noting that while reimbursement for TMVR limits growth in certain countries, the overall reimbursement landscape is favorable in Europe.
  • Of the four valves in the human heart (mitral valve, tricuspid valve, aortic valve and pulmonary valve), the mitral valve is most prone to regurgitation.
  • Mitral regurgitation (MR) can either be caused by a congenital defect or myxomatous degeneration of the valve.